DailyDoctor Archive Specialties Get app
Back to the 29 October 2026 edition

Pearl · 04 of 05

Ask about giant cell arteritis in every new polymyalgia

Screen every new polymyalgia patient for giant cell arteritis symptoms before starting low-dose steroids.

Polymyalgia rheumatica and giant cell arteritis overlap, and missing arteritis risks permanent visual loss. Every patient presenting with polymyalgia should be asked about cranial and systemic features before low-dose steroids are started.

Polymyalgia also has many mimics, including late-onset rheumatoid arthritis, malignancy and infection, so a poor or partial response to low-dose steroids is a reason to reconsider the diagnosis.

  • Ask about new headache, scalp tenderness, jaw claudication and visual disturbance.
  • Ask about fever, weight loss and limb claudication, which can signal large-vessel involvement.
  • Examine temporal arteries and check both radial pulses and arm blood pressures.
  • Reconsider the diagnosis if symptoms do not respond well to low-dose steroids within a few weeks.

Why it matters

Polymyalgia doses of steroid will not protect the eyes of a patient with unrecognised arteritis.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

raspondyloarthritisvasculitismyositis

Tomorrow morning, before your first patient

One edition a day for rheumatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app